e184 is an Advanced Research Funding Organization (ARFO) that supports frontier science and technology.
Advancing humanity through science and technology
get in touch
We are living in an exponential age. The challenge is that humans are not used to it. Our skills and capabilities are not growing at an ever-increasing rate, and even the population growth rate has slowed down, failing to align with an exponent. At e184, our mission is to invest in science and technology that transforms humans into exponential species.
Modern reproductive technologies are revolutionizing the landscape of healthcare and family planning by offering innovative solutions to infertility and genetic disorders, thus enabling countless individuals to achieve their dream of parenthood.
These advancements, including in vitro fertilization (IVF), in vitro gametogenesis (IVG), and gene editing techniques like CRISPR, are improving success rates for conception and allowing for the screening and prevention of hereditary diseases, ensuring healthier future generations.
Contact usNeurotechnology has evolved dramatically since the 1970s, which brought peripheral nerve stimulation and near-infrared spectroscopy, for example. Today, advances like optically pumped magnetometers, functional ultrasound, microelectrode arrays, and stentrodes revolutionised neural recording.
Mirroring Moore’s law, the number of neurons recorded simultaneously doubled every seven years from 1960 to 2010. These breakthroughs enabled speech decoding, motor function restoration, and tremor reduction. At e184, we aim to bring brain-machine interfaces (BMIs) into everyday life, transforming how we interact with technology.
Contact us
.png)
Kirill Eves is a visionary serial entrepreneur and founder, building successful industry-shaping fintech companies for over 15 years. His portfolio includes Unlimit.com, one of the largest global payment infrastructures, and Stable.com, USD3 and Blockchain settlement layer.
An eminent investor with a nack for groundbreaking start-ups, he developed the concept of e184, an advanced research funding organisation, during his time at Stanford School of Business, while thinking up solutions to the task of accelerating the emergence of critically important technologies that would advance human evolution in his campus room numbered e184 (hence the name). Kirill is a relentless techno-optimist and dreamer.
.png)
Alex is responsible for executing e184's vision by turning it into an actionable strategy and overseeing its day-to-day operations. He's an investment professional with experience that includes Draper X (a VC firm led by the legendary Tim Draper) and running his own investment banking advisory boutique. To stay up-to-date with the trends in different industries in which he has been involved, Alex developed a taste for knowing what's happening in technology and science.
Peter leads neurotech practice at e184. He was previously an investment manager at 7percent Ventures, a London-based deep tech fund. During his career, Peter invested across the aerospace, transportation, and agriculture sectors and the data stack.
As an angel/VC investor, Peter backed Beyond Aero, CoMind, Five AI, and QuestDB, among other things. Peter’s passion for neurotech was manifested in his writing and angel investing and eventually became his focus. When he's out of the office, you could find him at neuro conferences or smashed on the mats of a Brazilian jiu-jitsu academy.
Fernanda’s main focus at e184 is on assisted reproductive technologies (ART). Her background lies at the intersection of genetics, data, machine learning, and finance — a bit of everything.
A deeply curious mind, constantly exploring innovative ways to leverage the power of science and data within the HealthTech space. Her main goal is to help transform these insights into tangible products aimed at addressing health threats by facilitating and pioneering life science‐based companies, where she can leverage her diverse background in various fields as tools for driving positive change in healthcare and life sciences.
Zana is responsible for legal affairs at e184. Having previously worked at Clifford Chance as an associate, he has extensive experience in domestic and cross-border acquisition finance, project finance, and capital markets transactions. He has also worked on numerous M&As and equity investments, with involvement in high-profile projects across sectors including technology, energy, pharmaceuticals, and FMCG.
Zana is committed to staying at the forefront of industry trends and adapting legal strategies to meet the evolving needs of the portfolio companies.
